Company: ABBV
Filing Date: 2025-02-20
Form Type: 424B5
Source: 0001104659-25-015715
Chunk: 1

Company: AbbVie Inc.
Filing Date: 2025-02-20
Form: 424B5
Chunk 1
---
). The Company intends to use the net proceeds from the sale of the Notes, together with cash on hand, (a) to repurchase, redeem, satisfy and discharge, defease, make a tender offer for, or otherwise repay at maturity (i) all of its 3.600% senior notes due 2025, which have a stated maturity date of May 14, 2025, in an aggregate outstanding principal amount of $3.750 billion, and/or (ii) all of its 3.800% senior notes due 2025, which have a stated maturity date of March 15, 2025, in an aggregate outstanding principal amount of $2.890 billion, and/or (iii) all of the 3.800% senior notes due 2025 of Allergan Funding SCS (formerly known as Actavis Funding SCS), which have a stated maturity date of March 15, 2025, in an aggregate principal amount of $130.225 million, and, in each case, to pay any premium and accrued and unpaid interest in respect thereof, and/or (b) for general corporate purposes. The Company may redeem some or all of each series of Notes at any time at redemption prices described in this prospectus supplement under the caption “ Description of Notes — Optional Redemption .” Investing in the Notes involves risks. Please read “Risk Factors” included or incorporated by reference herein, as described beginning on page S-5of this prospectus supplement.

| ​             
 Per 2028 Note 
 Per 2030 Note 
 Per 2035 Note 
 Per 2055 Note | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | Publicoffering price(1) 
 ​                       
 ​                       
 ​                       
 ​                       | ​ 
 ​ 
 ​ 
 ​ |       99.867% 
       99.908% 
       99.857% 
       99.750% | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | Underwritingdiscount 
 ​                    
 ​                    
 ​                    
 ​                    | ​ 
 ​ 
 ​ 
 ​ |     0.250% 
     0.350% 
     0.450% 
     0.875% | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | Proceeds